Hong Kong Stock Exchange · Healthcare
Invest in Hangzhou Jiuyuan Genetic Biopharmaceutical stock from India
Indian and foreign residents can buy Hangzhou Jiuyuan Genetic Biopharmaceutical (2566) shares directly through Paasa.
By Paasa · Updated
Hangzhou Jiuyuan Genetic Biopharmaceutical at a glance
- Price
- HK$5.65+HK$0.00 (0.00%)
- Market cap
- HK$1.36B
- Day range
- HK$5.33 – HK$5.65
- P/E
- —
- Dividend yield
- —
- Volume
- 11.20K
- 1 month
- +10.25%
- 6 months
- -19.93%
- YTD
- -25.33%
- 1 year
- -45.93%
- 5 years
- —
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| 3SBio | 1530.HK | HK$15.07 | HK$37.69B |
| Mabwell-b | 2493.HK | HK$20.38 | HK$11.32B |
| Beijing Luzhu Biotechnology | 2480.HK | HK$15.01 | HK$2.99B |
| Shandong Boan Biotechnology | 6955.HK | HK$3.10 | HK$1.93B |
| HighTide Therapeutics | 2511.HK | HK$3.43 | HK$1.74B |
| Shanghai Bao Pharmaceuticals | 2659.HK | HK$11.35 | HK$1.73B |
| Guangzhou Innogen Pharmaceutl Grp | 2591.HK | HK$3.60 | HK$1.64B |
| Beijing Biostar Pharms | 2563.HK | HK$4.30 | HK$1.04B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Hangzhou Jiuyuan Genetic Biopharmaceutical from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 2566 and buy
Find Hangzhou Jiuyuan Genetic Biopharmaceutical by name or by its ticker, 2566, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in Hangzhou Jiuyuan Genetic Biopharmaceutical from India
What Hangzhou Jiuyuan Genetic Biopharmaceutical does
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally. The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-GCSF injection. Hangzhou Jiuyuan Genetic Biopharmaceutical operates in the Biotechnology industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Hangzhou Jiuyuan Genetic Biopharmaceutical stock from India?
Yes. Indian residents and NRIs can buy Hangzhou Jiuyuan Genetic Biopharmaceutical (2566) shares directly through Paasa. Hangzhou Jiuyuan Genetic Biopharmaceutical is listed on the Hong Kong Stock Exchange, in the Biotechnology industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full Hangzhou Jiuyuan Genetic Biopharmaceutical share?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$5.65 a share, size the order by the lot, not by the share.
How are Hangzhou Jiuyuan Genetic Biopharmaceutical dividends taxed for Indian investors?
Hangzhou Jiuyuan Genetic Biopharmaceutical trades on the Hong Kong Stock Exchange but is domiciled in China, so any withholding on its dividends follows that country's rules rather than those of Hong Kong. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Hangzhou Jiuyuan Genetic Biopharmaceutical shares?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.